Atlas Trials

Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects

Clinical trial NCT02981966 · COMPLETED

Trial details

NCT number
NCT02981966
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2019-05-23
Primary completion
2022-04-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.